272 related articles for article (PubMed ID: 30158289)
1. Inhibition of MALT1 Decreases Neuroinflammation and Pathogenicity of Virulent Rabies Virus in Mice.
Kip E; Staal J; Tima HG; Verstrepen L; Romano M; Lemeire K; Suin V; Hamouda A; Baens M; Libert C; Kalai M; Van Gucht S; Beyaert R
J Virol; 2018 Nov; 92(22):. PubMed ID: 30158289
[TBL] [Abstract][Full Text] [Related]
2. MALT1 Controls Attenuated Rabies Virus by Inducing Early Inflammation and T Cell Activation in the Brain.
Kip E; Staal J; Verstrepen L; Tima HG; Terryn S; Romano M; Lemeire K; Suin V; Hamouda A; Kalai M; Beyaert R; Van Gucht S
J Virol; 2018 Apr; 92(8):. PubMed ID: 29367251
[TBL] [Abstract][Full Text] [Related]
3. MALT1 Proteolytic Activity Suppresses Autoimmunity in a T Cell Intrinsic Manner.
Demeyer A; Skordos I; Driege Y; Kreike M; Hochepied T; Baens M; Staal J; Beyaert R
Front Immunol; 2019; 10():1898. PubMed ID: 31474984
[TBL] [Abstract][Full Text] [Related]
4. MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-κB and NLRP3 inflammasome activation.
Liu W; Guo W; Hang N; Yang Y; Wu X; Shen Y; Cao J; Sun Y; Xu Q
Oncotarget; 2016 May; 7(21):30536-49. PubMed ID: 27105502
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis.
Mc Guire C; Elton L; Wieghofer P; Staal J; Voet S; Demeyer A; Nagel D; Krappmann D; Prinz M; Beyaert R; van Loo G
J Neuroinflammation; 2014 Jul; 11():124. PubMed ID: 25043939
[TBL] [Abstract][Full Text] [Related]
6. Role of Malt1 protease activity in pathogenesis of inflammatory disorders mediated by FcγR signaling.
Nakamura Y; Yokoyama K; Igaki K; Tsuchimori N
Int Immunopharmacol; 2018 Mar; 56():193-196. PubMed ID: 29414650
[TBL] [Abstract][Full Text] [Related]
7. Rabies viruses of different virulence regulates inflammatory responses both in vivo and in vitro via MAPK and NF-κB pathway.
Liu SQ; Gao X; Xie Y; Wang Q; Zhu WY
Mol Immunol; 2020 Sep; 125():70-82. PubMed ID: 32652362
[TBL] [Abstract][Full Text] [Related]
8. Basis of rabies virus neurovirulence in mice: expression of major histocompatibility complex class I and class II mRNAs.
Irwin DJ; Wunner WH; Ertl HC; Jackson AC
J Neurovirol; 1999 Oct; 5(5):485-94. PubMed ID: 10568885
[TBL] [Abstract][Full Text] [Related]
9. A MALT1 inhibitor suppresses human myeloid DC, effector T-cell and B-cell responses and retains Th1/regulatory T-cell homeostasis.
Dumont C; Sivars U; Andreasson T; Odqvist L; Mattsson J; DeMicco A; Pardali K; Johansson G; Yrlid L; Cox RJ; Seeliger F; Larsson M; Gehrmann U; Davis AM; Vaarala O
PLoS One; 2020; 15(9):e0222548. PubMed ID: 32870913
[TBL] [Abstract][Full Text] [Related]
10. Mepazine Inhibits RANK-Induced Osteoclastogenesis Independent of Its MALT1 Inhibitory Function.
Meloni L; Verstrepen L; Kreike M; Staal J; Driege Y; Afonina IS; Beyaert R
Molecules; 2018 Nov; 23(12):. PubMed ID: 30513612
[TBL] [Abstract][Full Text] [Related]
11. MALT1--a universal soldier: multiple strategies to ensure NF-κB activation and target gene expression.
Afonina IS; Elton L; Carpentier I; Beyaert R
FEBS J; 2015 Sep; 282(17):3286-97. PubMed ID: 25996250
[TBL] [Abstract][Full Text] [Related]
12. T-bet Is Required for the Rapid Clearance of Attenuated Rabies Virus from Central Nervous System Tissue.
Lebrun A; Portocarrero C; Kean RB; Barkhouse DA; Faber M; Hooper DC
J Immunol; 2015 Nov; 195(9):4358-68. PubMed ID: 26408670
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological Inhibition of MALT1 Protease Leads to a Progressive IPEX-Like Pathology.
Martin K; Junker U; Tritto E; Sutter E; Rubic-Schneider T; Morgan H; Niwa S; Li J; Schlapbach A; Walker D; Bigaud M; Beerli C; Littlewood-Evans A; Rudolph B; Laisney M; Ledieu D; Beltz K; Quancard J; Bornancin F; Zamurovic Ribrioux N; Calzascia T
Front Immunol; 2020; 11():745. PubMed ID: 32425939
[TBL] [Abstract][Full Text] [Related]
14. MALT1-Deficient Mice Develop Atopic-Like Dermatitis Upon Aging.
Demeyer A; Van Nuffel E; Baudelet G; Driege Y; Kreike M; Muyllaert D; Staal J; Beyaert R
Front Immunol; 2019; 10():2330. PubMed ID: 31632405
[TBL] [Abstract][Full Text] [Related]
15. Interferon production and immune response induction in apathogenic rabies virus-infected mice.
Marcovistz R; Leal EC; Matos DC; Tsiang H
Acta Virol; 1994 Aug; 38(4):193-7. PubMed ID: 7533478
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological inhibition of MALT1 protease activity suppresses endothelial activation via enhancing MCPIP1 expression.
Li Y; Huang S; Huang X; Li X; Falcon A; Soutar A; Bornancin F; Jiang Z; Xin HB; Fu M
Cell Signal; 2018 Oct; 50():1-8. PubMed ID: 29913212
[TBL] [Abstract][Full Text] [Related]
17. Immune effector mechanisms required for protection to rabies virus.
Xiang ZQ; Knowles BB; McCarrick JW; Ertl HC
Virology; 1995 Dec; 214(2):398-404. PubMed ID: 8553540
[TBL] [Abstract][Full Text] [Related]
18. Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system.
Hooper DC; Morimoto K; Bette M; Weihe E; Koprowski H; Dietzschold B
J Virol; 1998 May; 72(5):3711-9. PubMed ID: 9557653
[TBL] [Abstract][Full Text] [Related]
19. Rabies virus infects mouse and human lymphocytes and induces apoptosis.
Thoulouze MI; Lafage M; Montano-Hirose JA; Lafon M
J Virol; 1997 Oct; 71(10):7372-80. PubMed ID: 9311815
[TBL] [Abstract][Full Text] [Related]
20. Role of virus-induced neuropeptides in the brain in the pathogenesis of rabies.
Weihe E; Bette M; Preuss MA; Faber M; Schäfer MK; Rehnelt J; Schnell MJ; Dietzschold B
Dev Biol (Basel); 2008; 131():73-81. PubMed ID: 18634468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
